INTEG-B.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Stats
Today's Volume	12 320.00
Average Volume	21 757.00
Market Cap	521.55M
EPS	SEK0.129
Earnings date	2022-12-01
P/E	-27.75
ATR14	SEK0.306 (1.08%)

Volume Correlation

Long: -0.20 (neutral)

Short: 0.65 (moderate)

Signal:(54.343) Neutral

Integrum AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Integrum AB (publ) Correlation - Currency/Commodity

-0.55
( weak negative )

-0.34
( neutral )

-0.39
( neutral )

-0.15
( neutral )

0.16
( neutral )

-0.55
( weak negative )

Integrum AB (publ) Financials

Annual	2023
Revenue:	SEK74.27M
Gross Profit:	SEK60.84M (81.92%)
EPS:	SEK-0.880

Q4	2023
Revenue:	SEK18.13M
Gross Profit:	SEK14.71M (81.11%)
EPS:	SEK0

Q3	2023
Revenue:	SEK18.68M
Gross Profit:	SEK12.90M (69.05%)
EPS:	SEK-0.740

Q2	2023
Revenue:	SEK20.23M
Gross Profit:	SEK17.44M (86.22%)
EPS:	SEK0.130

Integrum AB (publ)

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden.

Estimated
INTEG-B.ST Next Dividend
(Unknown) SEK0 Probabilty 0 %